Torigen Pharmaceuticals

1 follower


Torigen Pharmaceuticals is focused on veterinary cancer care. Their product, VetiVax, is a revolutionary cancer immunotherapy that uses the patient's own tumor cells to create a personalized treatment that educates the immune system to recognize the tumor as foreign.

Employees

11-50

Links


Org chart

Collapse
Mark Suckow
Chief Technology Officer
Ryan Clauson
VP of Research & Development
Troy Gobbett, PMP
Vice President of Operational Excellence
Mike Vaughn
Business Development Manager
Jon Wetzel
Business Development Manager